Pneumonia testing market (Pune)

Pneumonia testing market

Fortune Business Insights in a new report, titled, ?Pneumonia Testing Market Size, Share & Industry Analysis, Pneumonia Testing Market By End-user (Hospitals & Clinics, Diagnostic Centers, and Others), and Regional Forecast, By Type (Streptococcus-based, Legionella-based, Chlamydophila-based, Viral Pneumonia-based, Mycoplasma Pneumonia-based, and Others) By Product Type (Instruments and Reagents & Consumables)2023-2029. Pneumonia Testing Market will exhibit a CAGR of 6.0% between 2023 and 2029, and reach USD 912.5 million by 2029, and the Market value as per 2021 was USD 557.1 million. To gain more insights into the market with a detailed table of content and figures, Click Here: https://www.fortunebusinessinsights.com/pneumonia-testing-market-106787 The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. LIST OF KEY COMPANIES PROFILED: Quidel Corporation (U.S.) Abbott (U.S.) bioMérieux SA (France) Thermo Fisher Scientific Inc. (U.S.) INTEC (China) OpGen (U.S.) Meridian Bioscience, Inc. (U.S.) BD (Becton, Dickinson, and Company) (U.S.) Luminex Corporation (DiaSorin S.p.A.) (U.S.) To get more information on the regional analysis of this market visit https://www.fortunebusinessinsights.com/enquiry/sample/pneumonia-testing-market-106787